REAL-WORLD DATA (RWD) / REAL-WORD EVIDENCE (RWE) INSIGHTS
-
Meaningful Industry Change Means Balancing Tech And Human Touch
Technology and AI/ML are advancing at an unprecedented pace, and we must not lose sight of our industry's core: human-to-human interaction.
-
Embracing Hybrid Trial Design — How, When, & Why To Use It
Global Clinical Sciences & Operations Innovation Lead Lewis Millen talks about UCB’s approach to hybrid trial design, how and when it chooses to implement remote and virtual elements, and why a hybrid trial is beneficial to both the sponsor and the patient.
RWD/RWE RESOURCES
-
Pitfalls And Possibilities: EHRs To RWD Via EDC
Consider DIA GCP & QA Community Chair Terry Katz’s perspective on repurposing and analyzing EHR data for clinical research.
-
Outsourcing Data Management: Challenges And Benefits
Life sciences companies are grappling with a deluge of data. Yet strategic data management outsourcing offers potential benefits amidst regulatory and interoperability hurdles.
-
The Stakeholder Benefits Of EHR eSource In Clinical Trials
Discover the transformative power of EHR eSource integration through the eyes of a clinical research coordinator and project director in an adaptive platform trial.
-
CDW: An Evolving Product Category Speeds Access To Quality Data
Explore how exponential increases in third-party patient data have catalyzed the emergence of the clinical data workbench, representing a pivotal advancement in the evolving field of data management.
-
Accelerating Innovation In Clinical Trials With Real-World Data
Learn about the challenge to access and connect to real-world data (RWD) – including EHR, claims, lab, and other data types once patient data is de-identified for trial purposes.
-
Keep Up With These 5 Patient Engagement And Recruitment Trends
From decentralized trials to real world data, take a look at top trends, their impact on patient enrollment and more, as well as ways to stay ahead of the curve.
-
Readying Your Clinical Trial For Linkage With Real-World Data
Discover why the near ubiquity of real-world data (RWD) sources has prompted sponsors to consider RWD’s role in study programs and regulatory bodies to issue guidance on their use in clinical development.